Publikationen in Zusammenarbeit mit Forschern von University of Toronto (3)

2022

  1. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268

2021

  1. Evaluation of multiple transcriptomic gene risk signatures in male breast cancer

    npj Breast Cancer, Vol. 7, Núm. 1

2011

  1. p16 INK4a expression and breast cancer risk in women with atypical hyperplasia

    Cancer Prevention Research, Vol. 4, Núm. 12, pp. 1953-1960